Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?

To: Steve who wrote (260)	12/5/1998 2:58:00 AM
From: Larry Liebman	Read Replies (2) \| Respond to of 496

I began nibbling today at $13 1/2. I like the R&D program. I don't profess to know where the bottom lies(..sigh..) but believe with $7 in cash it is worth my consideration. If the charts are correct, the last time it traded this low was 1995, and the salient news was Gliadel! It seems that with the expansion and progress in clinical work, not to mention the mega-Amgen deal, the stock should command a significantly higher valuation.